| PD | Parkinson’s disease |
| PS | Parkinson Syndromes |
| AE | Adverse event |
| ADE | Adverse device effect |
| drTMS | deep repetitive transcranial magnetic stimulation |
| rTMS | repetitive transcranial magnetic stimulation |
| PFC | Prefrontal cortex |
| PD-AR | Parkinson’s Disease with predominant symptoms of akinesia and rigidity |
| aPS | Atypical Parkinson’s syndrome |
| PD-E | Parkinson’s Disease subtype of the equivalent type |
| PD-D | Parkinson’s Disease with Dementia |
| PSP | Progressive Supranuclear Palsy |
| sPS | symptomatic Parkinson’s syndrome |
| CMND | Combined Motor Neuron Disease |
| MSA | multiple system atrophy |
| MDS-UPDRS | Movement Disorder Society sponsored Unified Parkinson’s Disease Rating Scale |
| NRS | Numeric rating scale |
| MoCA | Montreal Cognitive Assessment |
| BDI-II | Beck Depression Inventory-II |
| BDI-FS | Beck Depression Inventory—Fast-Screen |